---
title: "Ocugen announces special shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293254445.md"
description: "Ocugen Inc. announced a virtual special shareholder meeting scheduled for September 21, 2026. The primary agenda item is a vote on amending the company's charter to increase authorized common shares by 250 million, raising the total to 640 million. Additionally, shareholders will vote on adjourning the meeting if necessary to secure sufficient votes for this share authorization increase."
datetime: "2026-07-20T21:01:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293254445.md)
  - [en](https://longbridge.com/en/news/293254445.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293254445.md)
generator: "portal-rs"
---

# Ocugen announces special shareholder meeting

-   Ocugen will hold a virtual special meeting of stockholders on Sept. 21, 2026. \* Votes will be held on a charter amendment to raise authorized common shares by 250,000,000 to 640,000,000. \* Stockholders will also vote on adjourning the meeting if needed to secure enough votes for the share authorization increase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-028979), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)

## Related News & Research

- [Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts](https://longbridge.com/en/news/296009571.md)
- [LPSN: Adjournment was approved to reconvene on September 2nd after insufficient votes for the merger](https://longbridge.com/en/news/296507504.md)
- [Valion Bio amends 8-K to report final vote tally on reverse stock split approval](https://longbridge.com/en/news/296531983.md)
- [Tempest Therapeutics special meeting adjourned after proposal fell short of required votes](https://longbridge.com/en/news/296266762.md)
- [MiniMed Group announces annual shareholder meeting](https://longbridge.com/en/news/296649574.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**